Skip to main content

Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001840574

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Verve Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of VERV: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1672174+9
Shares76.1M6.75M75.3M+5.89M (+8.5%)
Value$371.8M$33.0M$364.6M+$25.7M (+7.6%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Verve Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to VERV in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.7,276,347$35.2M0.00%
Schonfeld Strategic Advisors LLC2,407,203$11.7M0.09%
Braidwell LP623,980$3.02M0.09%
Acadian Asset Management LLC192,766$932.0K0.00%
Ikarian Capital, LLC170,000$822.8K0.26%
Acuta Capital Partners, LLC146,100$707.1K0.57%
HRT Financial LP126,859$613.0K0.00%
PFM Health Sciences, LP125,999$609.8K0.03%
XTX Topco Ltd103,348$500.2K0.04%
Boothbay Fund Management, LLC49,724$240.7K0.01%
Pale Fire Capital SE45,600$220.7K0.03%
Intech Investment Management LLC34,166$165.4K0.00%
SG Americas Securities, LLC29,954$145.0K0.00%
Verition Fund Management LLC28,714$139.0K0.00%
ExodusPoint Capital Management, LP22,227$108.0K0.00%
JustInvest LLC21,025$101.8K0.00%
Point72 (DIFC) Ltd17,143$83.0K0.01%
Aigen Investment Management, LP15,231$73.7K0.01%
E Fund Management Co., Ltd.13,554$65.6K0.00%
Teza Capital Management LLC11,107$53.8K0.01%
Cerity Partners LLC10,995$53.2K0.00%
Pathstone Holdings, LLC10,940$52.9K0.00%
PFG Investments, LLC10,900$52.8K0.00%
Creative Planning10,407$50.4K0.00%
Fox Run Management, L.L.C.10,077$48.8K0.01%
Shell Asset Management Co6,035$29.0K0.00%
Versant Capital Management, Inc323$1.56K0.00%
Sterling Capital Management LLC250$1.21K0.00%
NBC Securities, Inc.350$1.00K0.00%
Capital Performance Advisors LLP141$6820.00%
True Wealth Design, LLC31$1510.00%
Parallel Advisors, LLC23$1110.00%
Creekmur Asset Management LLC19$920.00%

Sold out (24)

Institutions that held Verve Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Verve Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VERV in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.6,620,004$32.3M
Susquehanna Fundamental Investments, LLC132,998$649.0K